Who is Liang, the founder of Jinyu Medicine?

Liang, male, born in February 1964/kloc-0, Han nationality, from Fengkai, Guangdong, joined the work in July, and/kloc-0 became a China citizen in April 1988. He holds a bachelor's degree (majoring in clinical medicine in Guangzhou Medical College) and a master's degree in business administration (majoring in MBA in National University of Singapore).

Liang is currently the Party Secretary, Chairman and CEO of Jinyu Medical (listed company of Shanghai Stock Exchange: 603882), and the Dean and Professor of Jinyu Inspection College of Guangzhou Medical University. According to the Hurun Report in 20021year, Liang's worth was 10 billion yuan, ranking 699th.

：

Guangzhou Jinyu Medical Inspection Group Co., Ltd. was incorporated in Guangzhou Administration for Industry and Commerce on May 26th, 2006. The legal representative is Liang, and its business scope includes investment consulting services. Commodity information consulting service; Biotechnology development services, etc.

Enterprise profile

Guangzhou Jinyu Medical Inspection Group Co., Ltd., headquartered in Guangzhou International Biological Island, has been actively exploring the operation mode of medical inspection outsourcing service in China since 1990s. Guangzhou Jinyu Medical Laboratory was formally established in 2003, mainly engaged in third-party medical examination and pathological diagnosis, and provided outsourcing services for medical examination and pathological diagnosis to various medical institutions.

Enterprise cooperation

On June, 2065438 16+0 1 day, Jinyu Medical and Huawei Technologies Co., Ltd. announced that they had trained an AI-assisted cervical cancer screening model based on pathomorphology and pathologist's diagnostic criteria for the first time.

Enterprise performance

2019 On April 26th, Guangzhou Jinyu Medical Inspection Group Co., Ltd. disclosed the annual report of 20 18. During the reporting period, the company achieved an operating income of 4,525,252,800 yuan, a year-on-year increase of 65,438+09.35%, and the net profit attributable to shareholders of listed companies was 233,265,438+04 million yuan.

Honor record

On June 9th, 2020, 65438, Jinyu Medical Inspection Group ranked 338th in 20 19 of Hurun China Top 500 Private Enterprises.

In March 2020, it was ranked 58th in "Top 2020 Hurun China Healthy Private Enterprises 100" with a market value of 25 billion yuan.

On 2021September 17, it won the nomination of the 4th China Quality Award.

investment in enterprise

2018 65438+1On October 23rd, Jinyu Medical subscribed for 50% equity of DRA Co., Ltd. (hereinafter referred to as "DRA Company") established by Lu Yuming team. Subsequently, as a wholly-owned subsidiary of DRA, the two parties jointly established Guangdong Jinyu Future Biotechnology Co., Ltd., focusing on the field of non-invasive prenatal testing, and established Jinyu Future Non-invasive Prenatal Testing Technology Center.

2018 On February 8th, Jinyu Future Noninvasive Prenatal Testing Technology Center, established by Jinyu Medical and Academician Lu Yuming, was officially unveiled.

corporate culture

Mission: Committed to the pursuit of human health, harmony and happiness.

Vision: To become a long-term leader in the third-party medical laboratory industry in China.

Values: honesty, innovation, cooperation and leadership responsibility.